Table C1.
Phenotype | π 1 | S | mc | wc | md | wd | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
SCZ 2014 | 5.28e−2 | 1.4e−6 | 3.6e−5 | −0.52 | 3.7e−3 | 87 | 352 | 1.4e−4 | 3.7e−4 | 519 | 7 | 1.07 |
Simulation | 1.05e−2 | 2.9e−6 | 3.2e−5 | −0.42 | 2.6e−3 | 59 | 174 | 1.1e−4 | 6.8e−3 | 559 | 119 | 1.08 |
BIP | 5.91e−2 | 1.2e−6 | 4.5e−5 | −0.40 | 4.0e−3 | 102 | 414 | —– | —– | —– | —– | 1.01 |
Simulation | 6.86e−3 | 1.6e−5 | 3.9e−5 | −0.40 | 5.1e−3 | 64 | 162 | —– | —– | —– | —– | 1.07 |
CD | 9.55e−4 | 5.0e−5 | 5.5e−4 | −0.64 | 1.9e−4 | 176 | 604 | 7.6e−2 | 2.0e−5 | —– | —– | 1.14 |
Simulation | 6.29e−4 | 1.1e−4 | 4.4e−4 | −0.84 | 1.8e−4 | 127 | 409 | 2.6e−2 | 9.8e−3 | 20 | 50 | 1.05 |
UC | 1.16e−3 | 3.6e−5 | 4.0e−4 | −0.67 | 1.9e−4 | 173 | 627 | 8.0e−2 | 1.6e−5 | —– | —– | 1.12 |
Simulation | 9.50e−4 | 5.5e−5 | 4.0e−4 | −0.65 | 1.8e−4 | 67 | 214 | 6.0e−4 | 9.5e−3 | —– | —– | 1.04 |
CAD | 1.88e−3 | 1.1e−5 | 9.2e−5 | −0.51 | 1.3e−4 | 171 | 683 | 5.3e−3 | 2.5e−5 | 102 | 7 | 0.92 |
Simulation | 4.01e−3 | 5.0e−6 | 3.2e−3 | −0.33 | 6.4e−6 | 45 | 143 | 1.8e−4 | 2.4e−5 | —– | —– | 1.02 |
AD Chr19 | 4.34e−4 | 1.0e−4 | 6.1e−3 | −0.57 | 3.2e−4 | 35 | 89 | —– | —– | —– | —– | 1.09 |
Simulation | 3.88e−4 | 7.4e−4 | 1.8e−3 | −0.60 | 3.9e−4 | —– | —– | —– | —– | —– | —– | 1.11 |
AD NoC19 | 1.05e−3 | 1.8e−5 | 2.6e−4 | −0.52 | 3.0e−5 | 264 | 6 | —– | —– | —– | —– | 1.04 |
Simulation | 2.52e−3 | 8.8e−6 | 9.8e−5 | −0.78 | 5.3e−5 | 708 | 757 | —– | —– | —– | —– | 1.00 |
ALS Chr9 | 1.12e−2 | 7.3e−6 | 3.9e−3 | −0.01 | 2.0e−5 | 106 | 6 | —– | —– | —– | —– | 0.99 |
Simulation | 5.23e−3 | 2.0e−5 | 1.2e−2 | 1.00 | 8.4e−6 | 144 | 7 | —– | —– | —– | —– | 1.03 |
Edu | 1.43e−2 | 1.7e−6 | 7.8e−6 | −0.44 | 6.4e−3 | 111 | 339 | 8.5e−5 | 2.8e−3 | 441 | 7 | 0.94 |
Simulation | 7.86e−3 | 4.4e−6 | 1.4e−5 | −0.45 | 3.4e−3 | 62 | 186 | 1.0e−4 | 4.7e−3 | 1031 | 8 | 1.03 |
IQ 2018 | 1.27e−2 | 7.5e−7 | 6.2e−6 | −0.51 | 4.8e−3 | 122 | 309 | 3.6e−5 | 3.0e−2 | 561 | 6 | 1.17 |
Simulation | 4.52e−3 | 8.4e−6 | 1.6e−5 | −0.49 | 2.1e−3 | 59 | 112 | 2.6e−5 | 9.2e−2 | 421 | 15 | 1.02 |
Height 2010 | 1.02e−3 | 4.1e−5 | 2.0e−4 | −0.44 | 2.0e−4 | 322 | 1243 | —– | —– | —– | —– | 0.90 |
Simulation | 1.02e−3 | 5.2e−5 | 2.2e−4 | −0.57 | 1.5e−4 | 152 | 478 | —– | —– | —– | —– | 1.02 |
Height 2014 | 1.15e−3 | 3.7e−5 | 1.6e−4 | −0.46 | 2.4e−4 | 242 | 929 | —– | —– | —– | —– | 1.57 |
Simulation | 8.26e−4 | 6.7e−5 | 3.9e−4 | −0.40 | 3.5e−5 | 1363 | 193 | —– | —– | —– | —– | 1.05 |
HDL | 2.54e−3 | 1.1e−5 | 4.5e−4 | −0.79 | 3.6e−5 | 143 | 599 | 2.2e−2 | 1.5e−5 | 66 | 7 | 0.91 |
Simulation | 9.39e−4 | 3.1e−5 | 1.1e−3 | −0.70 | 2.3e−5 | 68 | 217 | 9.8e−4 | 1.6e−4 | —– | —– | 1.02 |
LDL | 5.84e−3 | 3.3e−6 | 2.4e−4 | −0.52 | 5.1e−5 | 336 | 1417 | 7.3e−3 | 1.9e−6 | 346 | 6 | 0.92 |
Simulation | 3.86e−3 | 5.5e−6 | 3.3e−4 | −0.58 | 3.1e−5 | 2046 | 273 | —– | —– | —– | —– | 1.03 |
BMI GIANT 2015 | 1.54e−3 | 2.2e−5 | 4.5e−4 | 0.00 | 6.8e−6 | 288 | 12 | —– | —– | —– | —– | 0.85 |
Simulation | 1.09e−3 | 2.4e−5 | 7.9e−4 | 0.73 | 4.3e−6 | 440 | 7 | —– | —– | —– | —– | 1.02 |
TC | 1.15e−3 | 1.7e−5 | 6.2e− | −0.97 | 2.4e−5 | 140 | 583 | 2.9e−4 | 7.1e−4 | —– | —– | 0.92 |
Simulation | 7.16e−4 | 2.9e−5 | 2.1e−4 | −0.95 | 4.8e−5 | 255 | 822 | 5.0e−3 | 6.7e−4 | 83 | 108 | 1.01 |
π 1 is the overall proportion of the 11 million SNPs from the reference panel that are estimated to be causal. is the total prior probability multiplying the “c” Gaussian, which has variance , where H is the reference SNP heterozygosity. Note that is just a sigmoidal curve, and can be characterized quite generally by three parameters: the value at L = 1; the total LD value L = mc at the mid-point of the transition, i.e. (see the middle gray dashed lines in Figure 1, which shows examples of π1 times the function ); and the width wc of the transition, defined as the distance (in L) between where the curve falls to 95% and 5% of (distance between the flanking red dashed lines in Figure 1). The “d” Gaussian is similarly defined (but without the HS dependence in the variance). Note that for AD Chr19, AD NoC19, and ALS Chr9, π1 is the fraction of reference SNPs on chromosome 19, on the autosome excluding chromosome 19, and on chromosome 9, respectively. See Figures 6 and 7, and Supplementary Figures S1 and S2. Ninety-five percent confidence intervals for the parameter estimates for the real phenotypes are in Appendix Tables E1–E3. The simulations were run in a separate processing stream; we did not additionally calculate confidence intervals for the simulation parameter estimates, which would have required substantial code modification and extensive processing. However, we expect on heuristic grounds that they would be similar to those estimated for the real phenotypes.